Selected Publications

Pardo, O.E., Arcaro, A., Salerno, G., Tetley, T.D., Gout, I. and Seckl, M.J. Novel Cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells. Oncogene 20, (2001), 7658-7667

Seckl M.J., Fisher R.A., Salerno G., Rees H., Paradinas F.J., Foskett M., Newlands E.S. Choriocarcinoma and partial hydatidiform moles. Lancet 356, (2000), 36-39.

Seckl, M.J., Malholland, P., Bishop, A.E., Teale, J.D., Hales, C.N., Glaser, M., Watkins, S. and Seckl J.R. Hypoglycaemic coma due to an insulin secreting small cell carcinoma of the cervix. New Engl. J. Med. 341, (1999), 733-736

Seckl, M.J., Higgins, T. and Rozengurt, E. [DArg1, DTrp5,7,9, Leu11] Substance P coordinately inhibits bombesin and vasopressin induced signal transduction pathways in Swiss 3T3 cells. J. Biol. Chem. 271, (1996), 29435-29460

Seckl, M.J., Seufferlein, T. and Rozengurt, E. Lysophosphatidic acid depleted serum, hepatocyte growth factor and stem cell factor stimulate colony growth of small cell lung cancer through a calcium independent pathway. Cancer Res. 54, (1994), 6143-6147